Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Gastric antisecretory agents patented by Byk Gulden

May 23, 2002

GLP-2 analogue provides clinical, functional and structural improvement in SBS patients

May 22, 2002

Caspase inhibitor improves liver function tests with good safety in first clinical trial

May 22, 2002

Novel antiviral agents from Shionogi inhibit HCV RNA-dependent RNA synthase

May 16, 2002

Gasmotin launched in third Asian market

May 16, 2002

Extended pharmacokinetics, pharmacodynamics confirmed for Albuferon in primates

May 14, 2002

Initiation of phase II trial of SMART anti-gamma interferon antibody in Crohn's disease

May 10, 2002

Shire inlicenses mesalazine MMX technology for ulcerative colitis

May 10, 2002

DT031I identified as potential target in inflammatory diseases

May 8, 2002

Protonix delayed-release tablets approved for long-term treatment of Zollinger-Ellison syndrome

May 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...